Related Experiment Video
Updated: Feb 20, 2026

11:36
Author Spotlight: An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations
Published on: April 21, 2023
3.1K
Challenges in DNA microarray studies from the regulatory perspective.
1CDRH, U.S. Food and Drug Administration, Rockville, Maryland 20850, USA. samir.lababidi@fda.hhs.gov
Journal of Biopharmaceutical Statistics
|December 29, 2007
Summary
Genomic classifiers, which use DNA microarrays, show promise for revolutionizing disease diagnosis and treatment. This article discusses the significant challenges hindering their integration into clinical practice.
Area of Science:
- Genomics
- Molecular Diagnostics
- Bioinformatics
Background:
- Genomic classifiers utilize DNA microarray data for disease diagnosis and management.
- There is significant interest in applying these classifiers in clinical settings.
- Currently, few genomic classifiers are utilized in routine medical practice.
Purpose of the Study:
- To discuss the challenges associated with the development and validation of genomic classifiers.
- To highlight the difficulties in translating genomic classifier technology into clinical practice.
Main Methods:
- Review of current literature on genomic classifier development.
- Analysis of barriers to clinical implementation.
Main Results:
- Identified key challenges in the development and validation of genomic classifiers.
- Highlighted difficulties in the clinical adoption of these diagnostic tools.
Conclusions:
- Despite their potential, significant hurdles impede the widespread clinical use of genomic classifiers.
- Addressing these challenges is crucial for realizing the benefits of genomic medicine.
Related Concept Videos
DNA Microarrays
21.4K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
21.4K
Epigenetic Regulation
4.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.0K
Cis-regulatory Sequences
12.0K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
12.0K

